Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • World
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (Zephyr)
  • No Skin
Collapse
Peptide Critic Community Peptide Critic Community
  1. Peptide Forum
  2. Peptide Discussion
  3. New to peptides
Prize
Peptide Critic Case and Pens
Ends in
3814 entries · 1657 participants
Enter →

New to peptides

Scheduled Pinned Locked Moved Peptide Discussion
ss-31dosage-discussionbeginner-question
4 Posts 4 Posters 152 Views 1 Watching
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • M Offline
    M Offline
    member-8wbz9
    wrote last edited by member-8wbz9
    #1

    Im relatively new to peptides have been on Reta for a month now, and started DSIP yesterday. I’m interested in SS-31 but I’m it sure of dosing and overall protocol, basically what a cycle would look like. I’ve definitely watched videos that give suggestions but I also feel that this forum has great info so I wanted to ask what your expende has been and how you folks have decided to run it. Any insight is appreciated.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Stevepep
      wrote last edited by
      #2

      I would search the forum there are several threads on this

      1 Reply Last reply
      1
      • MyBM Offline
        MyBM Offline
        MyB
        wrote last edited by
        #3

        Randy’s protocol is a good place to start. https://community.peptidecritic.com/post/436
        Use the magnifying glass 🔍 to search ss-31 to explore past discussion.

        Follows research backed science, not “trust me” bro’s.

        1 Reply Last reply
        1
        • dontfyourlifeD Offline
          dontfyourlifeD Offline
          dontfyourlife
          wrote last edited by dontfyourlife
          #4

          Actually I would maybe do more research before spending $$ on SS-31.

          SS-31 works by binding to cardiolipin, a molecule that is broken in genetic disorders like Barth Syndrome but present in normal people. Because you have existing cardiolipin that is not broken/missing the peptide has nothing to "fix".

          The human MMPOWER 3 trials that showed even at a large dose of 40 milligrams a day SS-31 failed to beat a saline placebo for physical fatigue or endurance.

          https://pubmed.ncbi.nlm.nih.gov/37268435/

          There have been over 25 human clinical trials in total conducted on SS-31. All but one for Barth's syndrome failed to meet the goals vs placebo. The good news that it's very safe to take 🙂

          I also would really question the dosing protocols some clinics have- ask them where that information specifically came from.

          1 Reply Last reply
          1

          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

          With your input, this post could be even better 💗

          Register Login
          Reply
          • Reply as topic
          Log in to reply
          • Oldest to Newest
          • Newest to Oldest
          • Most Votes


          • Login

          • Login or register to search.
          • First post
            Last post
          0
          • Categories
          • Recent
          • Tags
          • Popular
          • World
          • Users
          • Groups